Clinical Trial Update: Clinical Study of DC Plus CIK for Patients With Relapse Acute Leukemia After Allo-HSCT [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical study evaluating dendritic cell plus cytokine-induced killer cell therapy for patients with relapse acute leukemia following allogeneic hemat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Cytokine-induced killer cell therapy (cytokine-induced killer cells)
• Dendritic cell therapy

Snippet

Sponsor: Affiliated Hospital to Academy of Military Medical Sciences | Conditions: Acute Leukemia | Phase 1, Phase 2 | Status: UNKNOWN